Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

New vaccine combats Meningococcal disease

  • Comment
A new vaccine to combat all forms of Meningococcal disease is being developed, the Health Protection Agency announced today.

A new vaccine to combat all forms of Meningococcal disease is being developed, the Health Protection Agency announced today.

The meningococcal Group C conjugate vaccine, introduced into the UK in 1999, has proved successful in reducing cases of that disease but there is still no effective vaccine against the Group B strains.

The HPA will work with the Serum Institute of India Ltd, which will combine components of the B vaccine with components of the A and C conjugate vaccines, which it already makes, as well as conjugates of the Y and W135 strains to produce and pan-meningococcal vaccine.

The new 5-in-1 vaccine will be manufactured in India and will have to undergo clinical trial testing in order to ensure that it is safe and effective before it can be made available.

The Agency's chief executive, Professor Pat Troop, said: 'This latest development marks the first step on the road to eliminating all forms of this devastating disease.'

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.